Intech Biopharm Corporation (TPEX:6461)

Taiwan · Delayed Price · Currency is TWD

18.30

+0.20 (1.10%)

Apr 20, 2026, 11:39 AM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research and Development Technology and Drug Trading Business	107.53M	39.78M	25.85M	23.65M	38.90M
Research and Development Technology and Drug Trading Business Growth	170.31%	53.90%	9.30%	-39.21%	84.30%
Total	107.53M	39.78M	25.85M	23.65M	38.90M
Total Growth	170.31%	53.90%	9.30%	-39.21%	84.30%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Taiwan	36.18M	21.85M	10.61M	10.34M
Taiwan Growth	65.54%	105.91%	2.66%	-27.70%
China	-	1.12M	9.32M	28.23M
China Growth	-	-87.99%	-66.98%	386.07%
Hong Kong	1.83M	1.75M	919.00K	-
Hong Kong Growth	4.98%	89.99%	-	-
Other	1.77M	1.13M	2.79M	-
Other Growth	56.91%	-59.60%	-	-
Malaysia	-	-	-	153.00K
Costa Rica	-	-	-	177.00K
Total	39.78M	25.85M	23.65M	38.90M
Total Growth	53.90%	9.30%	-39.21%	84.30%

Source: S&P Global Market Intelligence.